Luise Weigand
Company: Zelluna Immunotherapy
Job title: Head of Research
Seminars:
Developing MAGE-A4 specific TCR-NK cells for the treatment of solid tumors: combining optimized target specific TCR and innate killing potency 10:15 am
Download the full event guide to find out more on session detailsRead more
day: Day Two Track A - AM